←back to thread

Goldman Sachs asks in biotech Report: Is curing patients a sustainable business? (2018)

(www.cnbc.com)
249 points randycupertino | 1 comments | 16 Nov 25 23:01 UTC | HN request time: 0.195s | source
Show context
snowwrestler ◴[16 Nov 25 23:39 UTC] No.45949515[source]▶
It doesn’t matter if it is a sustainable business. People will do what they can to maximize their income now. If 10 companies are withholding a cure to milk the patients, any one of them can break from that strategy at any time, with near-instant financial reward and competitive advantage. It is not a stable equilibrium.
replies(3): >>45949532 #>>45949904 #>>45953315 #
idontwantthis ◴[16 Nov 25 23:41 UTC] No.45949532[source]▶
As long as government regulation prevents them from forming a cartel.
replies(3): >>45949579 #>>45950574 #>>45955111 #
1. thrance ◴[17 Nov 25 16:28 UTC] No.45955111[source]▶
And as long as those cartels aren't powerful enough to buy the government into submission.